DRMA

Dermata Therapeutics, Inc. - Common Stock (DRMA)

About Dermata Therapeutics, Inc. - Common Stock (DRMA)

Dermata Therapeutics, Inc. is a clinical-stage medical dermatology company that focuses on identifying, developing, and commercializing pharmaceutical product candidates for the treatment of medical and aesthetic skin diseases. The company was founded by David F. Hale and Gerald T. Proehl on December 8, 2014 and is headquartered in San Diego, CA.

Details

Daily high
$1.26
Daily low
$1.20
Price at open
$1.20
52 Week High
$8.00
52 Week Low
$1.10
Market cap
4.7M
Dividend yield
0.00%
Volume
49,258
Avg. volume
65,465
P/E ratio
-.22

Dermata Therapeutics, Inc. - Common Stock News

Details

Daily high
$1.26
Daily low
$1.20
Price at open
$1.20
52 Week High
$8.00
52 Week Low
$1.10
Market cap
4.7M
Dividend yield
0.00%
Volume
49,258
Avg. volume
65,465
P/E ratio
-.22